logo

For the Inventor, By the Inventor

Burlington, MA, United States of America

Charles E Hammond

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Biogen, Incorporated, Biogen Idec Ma Inc., Polaroid Corporation. Active years: 1982-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles E Hammond. Retrieved from https://idiyas.com/inventor/charles-e-hammond-x1m7qho0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0


Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 73(Granted Patents)


Company Filing History:

goldMedal8 out of 130 
 
Biogen, Incorporated
 patents
silverMedal1 out of 216 
 
Biogen Idec Ma Inc.
 patents
bronzeMedal1 out of 2,176 
 
Polaroid Corporation
 patents

Years Active: 1982-2006

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 7001921 - Cell adhesion inhibitors (2006-02-21),
2. 6875743 - Cell adhesion inhibitors (2005-04-05),
3. 6630512 - Cell adhesion inhibitors (2003-10-07),
4. 6624152 - Cell adhesion inhibitors (2003-09-23),
5. 6596687 - Cell adhesion inhibitors (2003-07-22),
6. 6376538 - Cell adhesion inhibitors (2002-04-23),
7. 6306840 - Cell adhesion inhibitors (2001-10-23),
8. 6248713 - Cell adhesion inhibitors (2001-06-19),
9. 6239108 - Cell adhesion inhibitors (2001-05-29),
10. 4348529 - Synthesis of cyclic disulfone compounds (1982-09-07),

Title: The Innovations of Charles E Hammond

Introduction

Charles E Hammond is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of cell adhesion inhibitors. With a total of 10 patents to his name, Hammond's work has the potential to impact the treatment of various inflammatory and autoimmune diseases.

Latest Patents

Hammond's latest patents focus on novel compounds that inhibit and prevent cell adhesion and related pathologies. These inventions include pharmaceutical formulations that utilize these compounds, offering methods for their application in therapeutic and prophylactic settings. The compounds developed by Hammond are particularly well-suited for treating a range of inflammatory and autoimmune diseases, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Hammond has worked with prominent companies in the biotechnology sector, including Biogen, Incorporated and Biogen Idec MA Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Hammond has collaborated with esteemed colleagues such as Steven P Adams and Ko-Chung Lin. These partnerships have further enriched his work and expanded the scope of his innovations.

Conclusion

Charles E Hammond's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of complex medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…